Simon Lennartz
Overview
Explore the profile of Simon Lennartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
849
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kottlors J, Hahnfeldt R, Gortz L, Iuga A, Fervers P, Bremm J, et al.
J Med Internet Res
. 2025 Feb;
27:e48328.
PMID: 39946168
Background: The latest advancement of artificial intelligence (AI) is generative pretrained transformer large language models (LLMs). They have been trained on massive amounts of text, enabling humanlike and semantical responses...
2.
Schoneck M, Rehbach N, Lotter-Becker L, Persigehl T, Lennartz S, Caldeira L
Life (Basel)
. 2025 Jan;
15(1).
PMID: 39860023
Kirsten Rat Sarcoma viral oncogene homolog (KRAS) is a frequently occurring mutation in non-small-cell lung cancer (NSCLC) and influences cancer treatment and disease progression. In this study, a machine learning...
3.
Nelles C, Ristow I, Juchems M, Wessling J, Ringe K, Fehrmann-Efferoth A, et al.
Rofo
. 2025 Jan;
PMID: 39848254
Online survey about the current status of CT protocols in hepatocellular carcinoma (HCC) in the year 2023/2024. Moreover, the usage of structured reporting using LI-RADS and mRECIST was surveyed and...
4.
Gertz R, Lennartz S, Kaya K, Wawer Matos Reimer R, Pennig L, Kottlors J, et al.
Int J Cardiovasc Imaging
. 2024 Dec;
41(2):303-314.
PMID: 39720959
To evaluate dual-layer dual-energy computed tomography (dlDECT)-based characterization of thrombus composition for differentiation of acute pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH). This retrospective single center cohort study...
5.
Eismann L, Rodler S, Buchner A, Strittmatter F, Alghamdi A, Lennartz S, et al.
Urol Int
. 2024 Dec;
:1-7.
PMID: 39647473
Introduction: Ureteral access sheaths (UASs) are widely used in the endoscopic treatment of urolithiasis. In modern medicine, radiation exposure from diagnostics and therapy is increasing; however, the impact of UAS...
6.
Tordjman M, Guarnera A, Horst C, OShea A, Yuan F, Zhang K, et al.
Radiology
. 2024 Dec;
313(3):e243310.
PMID: 39625376
No abstract available.
7.
Westhofen T, Buchner A, Lennartz S, Rodler S, Eismann L, Aydogdu C, et al.
World J Urol
. 2024 Oct;
42(1):585.
PMID: 39427278
Objective: To investigate the prognostic value of baseline health-related quality of life (HRQOL) for patients with intermediate-risk localized prostate cancer (IR-PCa) undergoing radical prostatectomy (RP). Methods: 4780 patients with IR-PCa...
8.
Cao J, Mroueh N, Mercaldo N, Lennartz S, Kongboonvijit S, Srinivas Rao S, et al.
Radiology
. 2024 Oct;
313(1):e232749.
PMID: 39377679
Background CT deep learning image reconstruction (DLIR) improves image quality by reducing noise compared with adaptive statistical iterative reconstruction-V (ASIR-V). However, objective assessment of low-contrast lesion detectability is lacking. Purpose...
9.
Nelles C, Graf M, Bernard P, Persigehl T, Grosse Hokamp N, Zopfs D, et al.
Eur Radiol
. 2024 Sep;
PMID: 39294304
Objectives: To compare immune response evaluation criteria in solid tumors (iRECIST) and response evaluation criteria in solid tumors (RECIST) 1.1 for response assessment of immune checkpoint inhibitor (ICI) therapy in...
10.
Gehrmann J, Soenarto D, Hidayat K, Beyer M, Quakulinski L, Alkarkoukly S, et al.
Front Med (Lausanne)
. 2024 Sep;
11:1396459.
PMID: 39257886
The Cancer of Unknown Primary (CUP) syndrome is characterized by identifiable metastases while the primary tumor remains hidden. In recent years, various data-driven approaches have been suggested to predict the...